BioSpace News Archive

Global Medical Ceramics Market Size to Reach USD 14.86 Billion in 2028, Says Reports and Data

Increasing incidence of accidents and rising number of surgical procedures are some key factors driving market revenue growth.

December 6, 2021
·
7 min read
Biotech Beach

Sorrento Receives Orders of COVISTIX for Commercial Launch in Brazil

Sorrento Therapeutics, Inc. announced that initial loading orders have been processed and scheduled for delivery later this year.

December 6, 2021
·
4 min read
Business

Dr. Arif Kamal Named First Chief Patient Officer for the American Cancer Society

The American Cancer Society has hired Dr. Arif Kamal as its first Chief Patient Officer to lead its patient support vision and strategic plans to improve the lives of cancer patients and their families.

December 6, 2021
·
3 min read
Business

Amphista Therapeutics Appoints Dr Martin Pass as CDO

Amphista Therapeutics, a leader in next generation targeted protein degradation (TPD) approaches, today announced the appointment of Dr Martin Pass, as Chief Development Officer (CDO).

December 6, 2021
·
2 min read
Biotech Bay

IGM Biosciences to Host Conference Call and Webcast to Review IGM-2323 Data Presented at the 63rd Annual ASH Meeting

IGM Biosciences, Inc. (Nasdaq: IGMS), a clinical-stage biotechnology company focused on creating and developing engineered IgM antibodies, today announced that the Company will host a conference call and live audio webcast on Saturday, December 11, 2021, at 7:30 p.m. EST.

December 6, 2021
·
1 min read
Freeline Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Dec 06, 2021

Freeline Therapeutics Holdings plc announced that on November 30, 2021, the Company granted its newly hired Chief Medical Officer, Pamela Foulds, MD, and another newly hired employee non-statutory options to purchase an aggregate of 240,000 and 7,200 of the Company’s ordinary shares, respectively

December 6, 2021
·
2 min read
Business

Revelation Biosciences Inc. Appoints Joseph A. Bellanti, M.D. to Scientific Advisory Board

Revelation Biosciences Inc. (Revelation), a clinical-stage life sciences company that is focused on the development of immunologic‑based therapies for the prevention and treatment of disease, today announced it has appointed Joseph A. Bellanti, M.D. to its scientific advisory board.

December 6, 2021
·
11 min read
Genetown

Nature Medicine Publishes Results from Two Registration Studies of AYVAKIT® (avapritinib) Showing Sustained Benefits in Patients with Advanced Systemic Mastocytosis

Blueprint Medicines Corporation (NASDAQ: BPMC) today announced two Nature Medicine publications on the registration-enabling EXPLORER and PATHFINDER trials of AYVAKIT® (avapritinib), highlighting its robust efficacy and safety datasets in advanced systemic mastocytosis (Advanced SM).

December 6, 2021
·
13 min read
Biotech Bay

Amgen Announces New Data Being Presented At ASH 2021

Amgen (NASDAQ: AMGN) today announced new data from its hematology pipeline and marketed portfolio to be presented at the 63rd American Society of Hematology (ASH) Annual Meeting & Exposition in Atlanta, Georgia, and virtually, from Dec. 11-14, 2021.

December 6, 2021
·
38 min read
Drug Development

Acadia Pharmaceuticals Announces Positive Top-line Results from the Pivotal Phase 3 Lavender Trial of Trofinetide in Rett Syndrome

Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced positive top-line results from the pivotal, Phase 3 Lavender™ study evaluating the efficacy and safety of trofinetide in 187 girls and young women aged 5-20 years with Rett syndrome.

December 6, 2021
·
9 min read